Current regulatory landscape and views from in-house counsel

  • Need for more compliance and enforcement and increased clarity about what products can be lawfully sold
  • Potential impact and changes at CTP in response to the Reagan-Udall Foundation’s Report
  • Upcoming rulemaking (e.g., menthol, VLNC)